<prompt> Omalizumab True statement is?Anti-IgEUsed as add on therapy in moderate to severe asthma prophylaxisGivn subcutaneouslyAll o above  <response>: Ans. is d i.e., All of above Anti-IgE Omalizumab. Omalizumab is a humanized monoclonal antibody that binds IgE, thereby preventing its binding to the high-affinity IgE receptor and blocking IgE-mediated allergic responses and inflammation. approved for patients 12 yr old with moderate to severe asthma, It is given every 2-4 wk subcutaneously based on body weight and serum IgE levels. Its clinical efficacy as an add-on therapy for patients with moderate to severe allergic asthma It is generally well tolerated, although local injection site reactions can occur 